Video: Assessing FDA Notice on Vinpocetine
In this video, INSIDER explores, in part, the industry's reaction to FDA's tentative determination that vinpocetine should not remain on the market as a dietary supplement.
December 7, 2016
Vinpocetine has been on the market as a dietary supplement for approximately the last 20 years. That could soon change thanks to a Federal Register notice that was published in September by FDA.
In this video, INSIDER explores:
-- FDA’s reasoning for its tentative conclusions that vinpocetine shouldn’t remain on the market as a dietary supplement;
-- reaction from trade associations to the Federal Register notice; and
-- a silver lining to the development for industry.
Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
You May Also Like